Long-term estrogen therapy for prostate cancer may predispose patients to severe intraoperative coronary spasm, necessitating careful anesthetic management.
May signal coronary spasm risk with estrogen therapy in prostate cancer; hypothesis-generating and requires prospective confirmation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Maeda et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: